Results 1 to 10 of about 244,121 (209)

DNAM1 and 2B4 Costimulatory Domains Enhance the Cytotoxicity of Anti-GPC3 Chimeric Antigen Receptor-Modified Natural Killer Cells Against Hepatocellular Cancer Cells in vitro

open access: yesCancer Management and Research, 2020
Yao Huang,1,2 Jianxing Zeng,2 Teng Liu,2 Qingyi Xu,2 Xianglin Song,2 Jinhua Zeng1,2 1Department of Hepatobiliary Surgery, The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, People’s Republic of China; 2Department of Hepatic
Huang Y   +5 more
doaj  

90Y-/166Ho- ‘Radiation lobectomy’ for liver tumors induces abnormal morphology and impaired drainage of peritumor lymphatics

open access: yesJHEP Reports
Background & Aims: High-dose unilobar radioembolization, or ‘radiation lobectomy’ (RL), is an induction therapy that achieves contralateral future liver remnant hypertrophy while simultaneously irradiating the tumor.
Daan Andel   +9 more
doaj   +1 more source

Exploring Glypican-3 as a Molecular Target in Hepatocellular Carcinoma: Perspectives on Diagnosis and Precision Immunotherapy Strategies

open access: yesFrontiers in Bioscience-Landmark
Liver cancer, primarily hepatocellular carcinoma (HCC), is the second leading cause of cancer-related deaths globally. It is typically characterized by rapid progression, poor prognosis, and high mortality rates.
Alireza Tojjari   +4 more
doaj   +1 more source

The Prognostic Significance of CTSV Expression in Patients with Hepatocellular Carcinoma

open access: yesInternational Journal of General Medicine
Yuping He,1,2,* Minghao Xu,2,3,* Chenhao Zhou,2,3 Qiongzhu Dong,2,4 Zhiqiu Hu,2,4,5 Ning Ren2– 4 1School of Health Science and Engineering, University of Shanghai for Science and Technology, Shanghai, 200093, People’s Republic of China; 2Key ...
He Y, Xu M, Zhou C, Dong Q, Hu Z, Ren N
doaj  

First-Line Treatment for Advanced Hepatocellular Carcinoma: A Three-Armed Real-World Comparison

open access: yesJournal of Hepatocellular Carcinoma
Robert Mahn,1,* Oscar André Glüer,1,* Farsaneh Sadeghlar,1 Christian Möhring,1 Taotao Zhou,1 Thomas Anhalt,1 Malte Benedikt Monin,1 Alexander Kania,2 Tim R Glowka,2 Georg Feldmann,3 Peter Brossart,3 Joerg C Kalff,2 Ingo GH Schmidt-Wolf,4 ...
Mahn R   +14 more
doaj  

Distinct immune signatures define hepatitis D- versus hepatitis B-associated hepatocellular carcinoma. [PDF]

open access: yesHepatol Commun
Glimmann S   +8 more
europepmc   +1 more source

Identification and credentialing of patient-derived xenograft models of invasive lobular carcinoma

open access: yesDisease Models & Mechanisms
Jagmohan Hooda   +12 more
doaj   +1 more source

Home - About - Disclaimer - Privacy